BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 24014052)

  • 1. The prognostic value of elevated ezrin in patients with osteosarcoma.
    Lun DX; Hu YC; Xu ZW; Xu LN; Wang BW
    Tumour Biol; 2014 Feb; 35(2):1263-6. PubMed ID: 24014052
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Meta-analysis of associations of the ezrin gene with human osteosarcoma response to chemotherapy and prognosis.
    Wang Z; He ML; Zhao JM; Qing HH; Wu Y
    Asian Pac J Cancer Prev; 2013; 14(5):2753-8. PubMed ID: 23803027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlations of ezrin expression with pathological characteristics and prognosis of osteosarcoma: a meta-analysis.
    Zhao DH; Zhu J; Wang WB; Dong F; Zhang Q; Fan HW; Zhang JZ; Wang YM
    ScientificWorldJournal; 2014; 2014():837543. PubMed ID: 25544963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical significance of microRNA-183/Ezrin axis in judging the prognosis of patients with osteosarcoma.
    Mu Y; Zhang H; Che L; Li K
    Med Oncol; 2014 Feb; 31(2):821. PubMed ID: 24352761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. microRNA-96 acts as a tumor suppressor gene in human osteosarcoma via target regulation of EZRIN.
    Yao Q; Pei Y; Zhang X; Xie B
    Life Sci; 2018 Jun; 203():1-11. PubMed ID: 29656060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Prognostic Role of Ezrin Immunoexpression in Osteosarcoma: A Meta-Analysis of Published Data.
    Li H; Min D; Zhao H; Wang Z; Qi W; Zheng S; Tang L; He A; Sun Y; Yao Y; Shen Z
    PLoS One; 2013; 8(6):e64513. PubMed ID: 23805177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comment on Lun et al. entitled "The prognostic value of elevated ezrin in patients with osteosarcoma".
    Li Z; Li Y
    Tumour Biol; 2014 May; 35(5):5051. PubMed ID: 24390666
    [No Abstract]   [Full Text] [Related]  

  • 8. Prognostic role of cytovillin expression in patients with osteosarcoma: a meta-analysis.
    Guo S; Bai R; Zhao W; Wang Y; Zhao Z; Feng W
    Tumour Biol; 2014 Jan; 35(1):469-73. PubMed ID: 23959472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic significance of cyclooxygenase-2 in osteosarcoma: a meta-analysis.
    Jiao G; Ren T; Lu Q; Sun Y; Lou Z; Peng X; Liang W; Guo W
    Tumour Biol; 2013 Oct; 34(5):2489-95. PubMed ID: 23857285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Down-regulation of miR-183 promotes migration and invasion of osteosarcoma by targeting Ezrin.
    Zhu J; Feng Y; Ke Z; Yang Z; Zhou J; Huang X; Wang L
    Am J Pathol; 2012 Jun; 180(6):2440-51. PubMed ID: 22525461
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significance of immunohistochemical expression of ezrin in non-metastatic high-grade osteosarcoma.
    Ferrari S; Zanella L; Alberghini M; Palmerini E; Staals E; Bacchini P
    Pediatr Blood Cancer; 2008 Apr; 50(4):752-6. PubMed ID: 17886294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression change of ezrin as a prognostic factor in primary osteosarcoma.
    Wang YF; Shen JN; Xie XB; Wang J; Huang G
    Med Oncol; 2011 Dec; 28 Suppl 1():S636-43. PubMed ID: 20859706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ezrin and alpha-smooth muscle actin are immunohistochemical prognostic markers in conventional osteosarcomas.
    Salas S; Bartoli C; Deville JL; Gaudart J; Fina F; Calisti A; Bollini G; Curvale G; Gentet JC; Duffaud F; Figarella-Branger D; Bouvier C
    Virchows Arch; 2007 Dec; 451(6):999-1007. PubMed ID: 17786474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A systematic review of p53 as a biomarker of survival in patients with osteosarcoma.
    Fu HL; Shao L; Wang Q; Jia T; Li M; Yang DP
    Tumour Biol; 2013 Dec; 34(6):3817-21. PubMed ID: 24014053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of microRNAs in osteosarcoma: A meta-analysis.
    Kim YH; Goh TS; Lee CS; Oh SO; Kim JI; Jeung SH; Pak K
    Oncotarget; 2017 Jan; 8(5):8726-8737. PubMed ID: 28060730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of the microRNA-29 family in patients with primary osteosarcomas.
    Hong Q; Fang J; Pang Y; Zheng J
    Med Oncol; 2014 Aug; 31(8):37. PubMed ID: 25015394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The clinical significance of changes in ezrin expression in osteosarcoma of children and young adults.
    Lugowska I; Mierzejewska E; Lenarcik M; Klepacka T; Koch I; Michalak E; Szamotulska K
    Tumour Biol; 2016 Sep; 37(9):12071-12078. PubMed ID: 27207343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ezrin expression predicts survival in stage IIB osteosarcomas.
    Kim MS; Song WS; Cho WH; Lee SY; Jeon DG
    Clin Orthop Relat Res; 2007 Jun; 459():229-36. PubMed ID: 17353802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunoexpression of Ezrin and CD44 in patients with osteosarcoma.
    Boldrini E; Peres SV; Morini S; de Camargo B
    J Pediatr Hematol Oncol; 2010 Aug; 32(6):e213-7. PubMed ID: 20562647
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Down-regulation of microRNA-26a and up-regulation of microRNA-27a contributes to aggressive progression of human osteosarcoma.
    Taheriazam A; Bahador R; Karbasy SH; Jamshidi SM; Torkaman A; Yahaghi E; Shakeri M
    Diagn Pathol; 2015 Sep; 10():166. PubMed ID: 26377680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.